BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9771796)

  • 1. The EAAT2 (GLT-1) gene in motor neuron disease: absence of mutations in amyotrophic lateral sclerosis and a point mutation in patients with hereditary spastic paraplegia.
    Meyer T; Münch C; Völkel H; Booms P; Ludolph AC
    J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):594-6. PubMed ID: 9771796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in the glutamate transporter EAAT2 gene do not cause abnormal EAAT2 transcripts in amyotrophic lateral sclerosis.
    Aoki M; Lin CL; Rothstein JD; Geller BA; Hosler BA; Munsat TL; Horvitz HR; Brown RH
    Ann Neurol; 1998 May; 43(5):645-53. PubMed ID: 9585360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms in the glutamate transporter gene EAAT2 in European ALS patients.
    Jackson M; Steers G; Leigh PN; Morrison KE
    J Neurol; 1999 Dec; 246(12):1140-4. PubMed ID: 10653305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutamate transporter EAAT2 splice variants occur not only in ALS, but also in AD and controls.
    Honig LS; Chambliss DD; Bigio EH; Carroll SL; Elliott JL
    Neurology; 2000 Oct; 55(8):1082-8. PubMed ID: 11071482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis.
    Lin CL; Bristol LA; Jin L; Dykes-Hoberg M; Crawford T; Clawson L; Rothstein JD
    Neuron; 1998 Mar; 20(3):589-602. PubMed ID: 9539131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is NIPA1-associated hereditary spastic paraplegia always 'pure'? Further evidence of motor neurone disease and epilepsy as rare manifestations.
    Tanti M; Cairns D; Mirza N; McCann E; Young C
    Neurogenetics; 2020 Oct; 21(4):305-308. PubMed ID: 32500351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The RNA of the glutamate transporter EAAT2 is variably spliced in amyotrophic lateral sclerosis and normal individuals.
    Meyer T; Fromm A; Münch C; Schwalenstöcker B; Fray AE; Ince PG; Stamm S; Grön G; Ludolph AC; Shaw PJ
    J Neurol Sci; 1999 Nov; 170(1):45-50. PubMed ID: 10540035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SPG7 mutations in amyotrophic lateral sclerosis: a genetic link to hereditary spastic paraplegia.
    Osmanovic A; Widjaja M; Förster A; Weder J; Wattjes MP; Lange I; Sarikidi A; Auber B; Raab P; Christians A; Preller M; Petri S; Weber RG
    J Neurol; 2020 Sep; 267(9):2732-2743. PubMed ID: 32447552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. More autosomal dominant SPG18 cases than recessive? The first AD-SPG18 pedigree in Chinese and literature review.
    Chen S; Zou JL; He S; Li W; Zhang JW; Li SJ
    Brain Behav; 2021 Dec; 11(12):e32395. PubMed ID: 34734492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A amyotrophic lateral sclerosis (ALS) 4 family misdiagnosed as hereditary spastic paraplegia-a case report].
    Taniguchi T; Hokezu Y; Okada T; Ishibashi M; Hashiguchi A; Matsuura E; Takashima H
    Rinsho Shinkeigaku; 2017 Nov; 57(11):685-690. PubMed ID: 29070749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intron 7 retention and exon 9 skipping EAAT2 mRNA variants are not associated with amyotrophic lateral sclerosis.
    Flowers JM; Powell JF; Leigh PN; Andersen P; Shaw CE
    Ann Neurol; 2001 May; 49(5):643-9. PubMed ID: 11357955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation of the caspase-3 cleavage site in the astroglial glutamate transporter EAAT2 delays disease progression and extends lifespan in the SOD1-G93A mouse model of ALS.
    Rosenblum LT; Shamamandri-Markandaiah S; Ghosh B; Foran E; Lepore AC; Pasinelli P; Trotti D
    Exp Neurol; 2017 Jun; 292():145-153. PubMed ID: 28342750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron-sensitive MR imaging of the primary motor cortex to differentiate hereditary spastic paraplegia from other motor neuron diseases.
    Cosottini M; Donatelli G; Ricca I; Bianchi F; Frosini D; Montano V; Migaleddu G; Del Prete E; Tessa A; Cecchi P; D'Amelio C; Siciliano G; Mancuso M; Santorelli FM
    Eur Radiol; 2022 Dec; 32(12):8058-8064. PubMed ID: 35593959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel UBQLN2 mutations linked to amyotrophic lateral sclerosis and atypical hereditary spastic paraplegia phenotype through defective HSP70-mediated proteolysis.
    Teyssou E; Chartier L; Amador MD; Lam R; Lautrette G; Nicol M; Machat S; Da Barroca S; Moigneu C; Mairey M; Larmonier T; Saker S; Dussert C; Forlani S; Fontaine B; Seilhean D; Bohl D; Boillée S; Meininger V; Couratier P; Salachas F; Stevanin G; Millecamps S
    Neurobiol Aging; 2017 Oct; 58():239.e11-239.e20. PubMed ID: 28716533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cortical excitability changes distinguish the motor neuron disease phenotypes from hereditary spastic paraplegia.
    Geevasinga N; Menon P; Sue CM; Kumar KR; Ng K; Yiannikas C; Kiernan MC; Vucic S
    Eur J Neurol; 2015 May; 22(5):826-31, e57-8. PubMed ID: 25683471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutamate transporter gene expression in amyotrophic lateral sclerosis motor cortex.
    Bristol LA; Rothstein JD
    Ann Neurol; 1996 May; 39(5):676-9. PubMed ID: 8619555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative splicing of the glutamate transporter EAAT2 (GLT-1).
    Meyer T; Münch C; Knappenberger B; Liebau S; Völkel H; Ludolph AC
    Neurosci Lett; 1998 Jan; 241(1):68-70. PubMed ID: 9502218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics of primary lateral sclerosis.
    Silani V; Corcia P; Harms MB; Rouleau G; Siddique T; Ticozzi N
    Amyotroph Lateral Scler Frontotemporal Degener; 2020 Nov; 21(sup1):28-34. PubMed ID: 33602012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary spastic paraplegia: More than an upper motor neuron disease.
    Parodi L; Fenu S; Stevanin G; Durr A
    Rev Neurol (Paris); 2017 May; 173(5):352-360. PubMed ID: 28449883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenoconversion from Spastic Paraplegia to ALS/FTD Associated with
    Theuriet J; Pegat A; Leblanc P; Vukusic S; Cazeneuve C; Millecamps S; Banneau G; Guillaud-Bataille M; Bernard E
    Genes (Basel); 2021 Nov; 12(12):. PubMed ID: 34946825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.